UnitedHealthcare Accuses Dallas Labs Of $100M Fraud
Law360, New York (January 27, 2017, 2:33 PM EST) -- UnitedHealthcare Insurance Co. on Thursday lobbed multiple federal claims against Dallas-based Next Health LLC and several subsidiaries that perform drug and genetic laboratory testing, saying that the companies defrauded the insurer of more than $100 million over several years through improper billing connected to a physician and referral source kickback scheme.
In an 81-page complaint, UnitedHealthcare detailed an array of various alleged kickback schemes involving unnecessary and expensive drug testing coordinated through Next Health, its subsidiaries and individual agents that cost the insurer and several self-funded insurance plans millions of dollars in charges for unlawful commercial insurance claims.
According to the...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!